Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.89B | $2.95B | -1.92% |
Cost of Revenue | $1.89B | $1.82B | +4.07% |
Gross Profit | $998.5M | $1.13B | -11.57% |
Operating Income | $569.9M | $676M | -15.70% |
Net Income | $492.7M | $593.4M | -16.97% |
EPS (Basic) | $6.75 | $7.98 | -15.41% |
EPS (Diluted) | $6.69 | $7.88 | -15.10% |
R&D Expense | $69.1M | $68.4M | +1.02% |
SG&A Expense | $338.5M | $353.4M | -4.22% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $3.64B | $3.83B | -4.86% |
Current Assets | $1.54B | $1.94B | -20.57% |
Total Liabilities | $961.1M | $948.5M | +1.33% |
Current Liabilities | $550.4M | $671.8M | -18.07% |
Stockholders' Equity | $2.68B | $2.88B | -6.90% |
Cash & Equivalents | $484.6M | $853.9M | -43.25% |
Long-Term Debt | $202.6M | $206.8M | -2.03% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $653.4M | $776.5M | -15.85% |
Investing Cash Flow | $-378.7M | $-368.7M | -2.71% |
Financing Cash Flow | $-622.6M | $-459.6M | -35.47% |
Share Buybacks | $560.9M | $438.3M | +27.97% |
D&A | $155.4M | $137.3M | +13.18% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 34.5% | 38.3% | -3.77% |
Operating Margin | 19.7% | 22.9% | -3.22% |
Net Margin | 17.0% | — | — |
ROE | 18.4% | — | — |
ROA | 13.5% | — | — |
Current Ratio | $2.795 | — | — |
Debt to Equity | $0.358 | — | — |
Other companies in Life Sciences Tools & Services